High level of fluorescent oxidation products and worsening of asthma control over time

High Fluorescent oxidation products level (FlOPs), a global oxidative stress biomarker, was associated cross-sectionally with poor asthma outcomes but its longitudinal association with asthma evolution has never been examined. We aimed to study the associations between FlOPs level at baseline and ch...

Full description

Saved in:
Bibliographic Details
Published inRespiratory research Vol. 20; no. 1; pp. 203 - 4
Main Authors Akiki, Zeina, Andrianjafimasy, Miora, Zerimech, Farid, Le Moual, Nicole, Siroux, Valérie, Dumas, Orianne, Matran, Régis, Nadif, Rachel
Format Journal Article
LanguageEnglish
Published England BioMed Central Ltd 06.09.2019
BioMed Central
BMC
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:High Fluorescent oxidation products level (FlOPs), a global oxidative stress biomarker, was associated cross-sectionally with poor asthma outcomes but its longitudinal association with asthma evolution has never been examined. We aimed to study the associations between FlOPs level at baseline and changes in current asthma, asthma attacks and asthma control status over 8 years. We used data from the second survey of the French EGEA cohort study as baseline and the third survey as follow-up. At baseline, the mean age of the 489 participants with ever asthma was 39 (± 16) years, 49% were women. Among participants with controlled asthma at baseline, high FlOPs level was significantly associated with worsening of asthma control at follow-up (odds-ratio adjusted for age, sex and smoking status (95% CI): 2.27 (1.32-3.90). No other significant associations were observed. In conclusion, results suggest FlOPs as a predictor of asthma evolution in adults and a good candidate marker in asthma management.
Bibliography:PMCID: PMC6731560
ISSN:1465-993X
1465-9921
1465-993X
1465-9921
DOI:10.1186/s12931-019-1173-0